JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB57573

Anti-SMURF1 antibody [1D7]

Be the first to review this product! Submit a review

|

(39 Publications)

Mouse Monoclonal SMURF1 antibody. Carrier free. Suitable for Flow Cyt, WB, IHC-P, ICC/IF and reacts with Human samples. Cited in 39 publications. Immunogen corresponding to Recombinant Fragment Protein within Human SMURF1 aa 150 to C-terminus.

View Alternative Names

KIAA1625, SMURF1, E3 ubiquitin-protein ligase SMURF1, hSMURF1, HECT-type E3 ubiquitin transferase SMURF1, SMAD ubiquitination regulatory factor 1, SMAD-specific E3 ubiquitin-protein ligase 1

4 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SMURF1 antibody [1D7] (AB57573)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SMURF1 antibody [1D7] (AB57573)

SMURF1 antibody (ab57573) used in immunohistochemistry at 2ug/ml on formalin fixed and paraffin embedded human stomach.

This image was generated using the ascites version of the product.

Immunocytochemistry/ Immunofluorescence - Anti-SMURF1 antibody [1D7] (AB57573)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-SMURF1 antibody [1D7] (AB57573)

ICC/IF image of ab57573 stained HeLa cells. The cells were 4% formaldehyde fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab57573, 5μg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-mouse IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43μM.

This image was generated using the ascites version of the product.

Flow Cytometry - Anti-SMURF1 antibody [1D7] (AB57573)
  • Flow Cyt

Unknown

Flow Cytometry - Anti-SMURF1 antibody [1D7] (AB57573)

Overlay histogram showing MCF7 cells stained with ab57573 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab57573, 1μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG2a [ICIGG2A] (ab91361, 1μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed.
This image was generated using the ascites version of the product.

Western blot - Anti-SMURF1 antibody [1D7] (AB57573)
  • WB

Unknown

Western blot - Anti-SMURF1 antibody [1D7] (AB57573)

SMURF1 antibody (ab57573) at 1ug/lane + HeLa cell lysate at 25ug/lane.

This image was generated using the ascites version of the product.

All lanes:

Western blot - Anti-SMURF1 antibody [1D7] (ab57573)

Predicted band size: 86 kDa

false

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

1D7

Isotype

IgG2a

Light chain type

kappa

Carrier free

Yes

Reacts with

Human

Applications

WB, IHC-P, Flow Cyt, ICC/IF

applications

Immunogen

Recombinant Fragment Protein within Human SMURF1 aa 150 to C-terminus. The exact immunogen used to generate this antibody is proprietary information.

Q9HCE7

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p><a href='/en-us/products/primary-antibodies/mouse-igg2c-kappa-monoclonal-18c8bc7ad10-isotype-control-ab170191'>ab170191</a> - Mouse monoclonal IgG2a, is suitable for use as an isotype control with this antibody.</p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>" } } }

Product details

This product was changed from ascites to tissue culture supernatant on 15 May 2019. Please note that the dilutions may need to be adjusted accordingly. If you have any questions, please do not hesitate to contact our scientific support team.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.4 Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

SMURF1 also known as SMAD-specific E3 ubiquitin protein ligase 1 functions as an E3 ubiquitin ligase involved in the targeted degradation of proteins. This protein weighs approximately 72 kDa and expresses primarily in various human tissues including bone lung and kidney. SMURF1 plays an essential role in regulating protein turnover by tagging substrates for proteasomal degradation. It interacts with substrates through a C2 domain which aids in membrane localization and substrate recognition effectively controlling cellular protein levels and their functions.
Biological function summary

SMURF1 influences numerous cellular processes such as bone morphogenetic protein (BMP) signaling by regulating the availability and stability of signaling molecules. It does not function in isolation; it is a component of a ubiquitin-proteasome system complex that includes other cofactors assisting its activity. SMURF1 therefore affects cell growth differentiation and homeostasis by managing signal transduction pathways critical for these cellular activities.

Pathways

SMURF1 is involved in the BMP and Wnt signaling pathways. Both are fundamental for various biological activities including embryonic development and cell cycle regulation. Within these pathways SMURF1 influences the activity of SMAD6 and related proteins modulating their turnover and impact on downstream signaling processes. These pathways also interact with other cellular pathways but SMURF1's specific role remains concentrated on modulating protein ubiquitination events.

SMURF1 has been linked to cancer and osteoporosis. Its dysregulation can disrupt normal cellular signaling contributing to tumorigenesis or impaired bone maintenance. In cancer its interaction with proteins such as SMAD7 can alter cell signaling promoting uncontrolled cell growth. In osteoporosis SMURF1's regulation of bone remodeling processes might be compromised leading to decreased bone mass and fragility. Understanding SMURF1's roles may open avenues for therapeutic interventions in these disorders.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

E3 ubiquitin-protein ligase that acts as a negative regulator of BMP signaling pathway. Mediates ubiquitination and degradation of SMAD1 and SMAD5, 2 receptor-regulated SMADs specific for the BMP pathway. Promotes ubiquitination and subsequent proteasomal degradation of TRAF family members and RHOA. Promotes ubiquitination and subsequent proteasomal degradation of MAVS (PubMed : 23087404). Acts as an antagonist of TGF-beta signaling by ubiquitinating TGFBR1 and targeting it for degradation (PubMed : 21791611). Plays a role in dendrite formation by melanocytes (PubMed : 23999003).
See full target information SMURF1

Publications (39)

Recent publications for all applications. Explore the full list and refine your search

Cell & bioscience 15:124 PubMed40877964

2025

Enriched environment inhibits GLT-1 ubiquitination by downregulating SMURF1 to attenuate ischemic brain injury induced excitotoxicity.

Applications

Unspecified application

Species

Unspecified reactive species

Yi Zhang,Wen Liu,Tao Huang,Lingling Liu,Xiuping Chen

Histology and histopathology :18974 PubMed40772306

2025

Suppressing SMURF1 to preserve GSTM2: An approach to reducing gastric cancer aggressiveness and .

Applications

Unspecified application

Species

Unspecified reactive species

Guoming Ma,Jingwu Li,Yuanting Lu,Weiwei Zuo

Gastroenterology report 13:goaf051 PubMed40584147

2025

BMP6 ubiquitination mediated by SMURF1 suppresses ferroptosis and diminishes sensitivity to doxorubicin in gastric cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Shuzhen Xu,Qingqi Zheng,Chunlin Chen,Zhenfa Wang,Guoyan Liu

Frontiers in oncology 15:1538335 PubMed40342823

2025

Expression of SMURF family in pancreatic cancer and its effect on cell proliferation and migration.

Applications

Unspecified application

Species

Unspecified reactive species

Chen Zhang,Caoyi Li,Long Wu,Yuan Wang,Ke Huang,Xu Yang,Sai Zhao,Haoran Zhu,Lin Shi,Jian Wang

Oncology letters 29:143 PubMed39850720

2025

Overexpression of miR‑424‑5p reduces cisplatin resistance by downregulating SMURF1 in gastric cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Daohan Wang,He Cui,Yongjia Yan,Weihua Fu,Li Lu

Autophagy 21:530-547 PubMed39324484

2024

SMURF1 mediates damaged lysosomal homeostasis by ubiquitinating PPP3CB to promote the activation of TFEB.

Applications

Unspecified application

Species

Unspecified reactive species

Qin Xia,Xuan Liu,Lu Zhong,Jun Qu,Lei Dong

Cancer science 115:3466-3480 PubMed39118482

2024

CLG promotes mTOR/ULK1 pathway-mediated autophagy to inhibit OS development by inhibiting TRAF6-mediated FLT3 ubiquitination.

Applications

Unspecified application

Species

Unspecified reactive species

Xiongjie Huang,Yanran Huang,Bin Peng,Junfang Wang,Huiyu Tang,Yanming Chen

Nature communications 15:2974 PubMed38582895

2024

Systematic HOIP interactome profiling reveals critical roles of linear ubiquitination in tissue homeostasis.

Applications

Unspecified application

Species

Unspecified reactive species

Yesheng Fu,Lei Li,Xin Zhang,Zhikang Deng,Ying Wu,Wenzhe Chen,Yuchen Liu,Shan He,Jian Wang,Yuping Xie,Zhiwei Tu,Yadi Lyu,Yange Wei,Shujie Wang,Chun-Ping Cui,Cui Hua Liu,Lingqiang Zhang

Autophagy 20:735-751 PubMed37909662

2023

SMURF1 controls the PPP3/calcineurin complex and TFEB at a regulatory node for lysosomal biogenesis.

Applications

Unspecified application

Species

Unspecified reactive species

Qin Xia,Hanfei Zheng,Yang Li,Wanting Xu,Chengwei Wu,Jiachen Xu,Shanhu Li,Lingqiang Zhang,Lei Dong

Cell death & disease 14:361 PubMed37316499

2023

SMURF1 attenuates endoplasmic reticulum stress by promoting the degradation of KEAP1 to activate NRF2 antioxidant pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Lei Dong,Mengchuan Xu,Yang Li,Wanting Xu,Chengwei Wu,Hanfei Zheng,Zhenyu Xiao,Guochen Sun,Lei Ding,Xiaobo Li,Wenming Li,Liying Zhou,Qin Xia
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com